Machatha Stephen's Form 4 filing
Aldeyra Therapeutics, Inc. (ALDX) · filed Mar 12, 2024
- Accession no.
- 0000950170-24-030311
- Filed
- Mar 12, 2024
- Trade date
- Mar 9-12, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $98.6K. It was filed 3 days after the trade.
This filing was later replaced by the amendment 0000950170-24-045113 (Apr 17, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Machatha StephenCIK 0001836354 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Common Stock | SSaleDisposed | −18,231 | $3.41 | −$62,167.71 | 255,032 | Direct | |
| Mar 12, 2024 | Common Stock | SSaleDisposed | −11,537 | $3.16 | −$36,456.92 | 243,495 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2024 | Common Stock | AGrant or awardAcquired | +405,450 | $0.00 | $0 | 405,450 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.